Literature DB >> 3334825

Hearing recovery following suboccipital excision of acoustic neuroma.

S A Telian1, J L Kemink, P Kileny.   

Abstract

Improvement of hearing after excision of an acoustic neuroma has been observed infrequently. We present a case of dramatic recovery of hearing in a patient with a 1-cm acoustic neuroma whose pure-tone thresholds and speech discrimination had profoundly deteriorated while she awaited surgical therapy. Postoperatively, her hearing in the affected ear is equal to that in her other ear, and her speech discrimination exceeds that of her best preoperative audiogram. Issues related to hearing preservation and improvement after acoustic tumor surgery are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3334825     DOI: 10.1001/archotol.1988.01860130089021

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  5 in total

1.  Remarkable restoration of speech discrimination after removal of jugular foramen schwannoma: a case report.

Authors:  Hiroko Monobe; Akio Morita; Toshihisa Murofushi
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-03       Impact factor: 2.503

2.  Clinical features of vestibular schwannomas in patients who experience hearing improvement after surgery.

Authors:  Michihiro Kohno; Shigeo Sora; Hiroaki Sato; Masanobu Shinogami; Hidehiko Yoneyama
Journal:  Neurosurg Rev       Date:  2014-12-21       Impact factor: 3.042

Review 3.  Hearing improvement after vestibular schwannoma surgery in the era of the hearing preservation rule - case report and literature review.

Authors:  Zdenek Fik; Jan Lazak; Silvie Hruba; Zdenek Cada; Eduard Zverrna; Jan Betka
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-12-09       Impact factor: 1.648

4.  Hearing improvement after tumor removal in a vestibular schwannoma patient with severe hearing loss.

Authors:  Y Inoue; K Ogawa; J Kanzaki
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-08       Impact factor: 2.503

Review 5.  Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Authors:  Scott R Plotkin; Chris Halpin; Jaishri O Blakeley; William H Slattery; D Bradley Welling; Susan M Chang; Jay S Loeffler; Gordon J Harris; A Gregory Sorensen; Michael J McKenna; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.